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Ig and T cell receptor variable region exons are 
assembled from component V, D, and J gene 
segments via V(D)J recombination. V(D)J re-
combination  is  initiated  in  developing  lym-
phocytes by the recombination-activating gene 
(RAG) endonuclease, which is comprised of   
the RAG1 and RAG2 proteins (Matthews and   
Oettinger, 2009). RAG endonuclease introduces 
DNA double strand breaks at the borders of V, 
D, or J segments, which are then joined by clas-
sical nonhomologous end-joining to form com-
plete V(D)J exons (Jung and Alt, 2004; Rooney 
et  al.,  2004; Weterings  and  Chen,  2008).  In   
developing B lineage cells, the Ig heavy (IgH) 
chain variable region exon is assembled first in 
progenitor (pro) B cells, followed by Ig light (IgL) 
chain V-to-J recombination in precursor (pre)   
B cells (Bassing et al., 2002). Productive assembly 
of both IgH and IgL variable region exons gives 
rise to a diverse repertoire of IgM-expressing 
early lineage and immature B cell derived from 
fetal liver cultures (IBCs). Deficiency of either 
the RAG1 or RAG2 protein leads to a complete 
severe combined immune deficiency (SCID) as a 
result of inability to initiate V(D)J recombination 
(Schwarz et al., 1996). Mutations in mice or 
humans that severely impair, but do not totally 
block RAG1 or RAG2 function, can lead to a 
“leaky”  SCID  phenotype  in  which  there  are 
low numbers of peripheral B or T lymphocytes 
(Villa et al., 2001).
Upon  activation  by  antigen  in  peripheral 
lymphoid organs, mature B cells may undergo 
IgH class-switch recombination (CSR), a pro-
cess in which the IgH  constant region exons 
(C) are deleted and replaced by one of several 
sets of downstream CH exons (e.g., C, C, and 
C), termed CH genes. CSR is the basis for   
IgH  switching  from  IgM  to  other  Ig  classes   
(e.g., IgG, IgE, or IgA). CSR occurs within switch 
regions (S), which are 1–10-kb sequences lo-
cated 5 to each set of CH genes (Chaudhuri   
et al., 2007). During CSR, DNA double-strand 
breaks (DSBs) are specifically induced in a donor 
S region (S) upstream of C and a downstream 
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Immunoglobulin heavy chain (IgH) class-switch recombination (CSR) replaces initially 
expressed C (IgM) constant regions (CH) exons with downstream CH exons. Stimulation of 
B cells with anti-CD40 plus interleukin-4 induces CSR from C to C1 (IgG1) and C (IgE), 
the latter of which contributes to the pathogenesis of atopic diseases. Although C CSR 
can occur directly from C, most mature peripheral B cells undergo CSR to C indirectly, 
namely from C to C1, and subsequently to C. Physiological mechanisms that influence 
CSR to C1 versus C are incompletely understood. In this study, we report a role for B cell 
developmental maturity in IgE CSR. Based in part on a novel flow cytometric IgE CSR assay, 
we show that immature B cells preferentially switch to IgE versus IgG1 through a mecha-
nism involving increased direct CSR from C to C. Our findings suggest that IgE dysregu-
lation in certain immunodeficiencies may be related to impaired B cell maturation.
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Noncommercial–Share  Alike  3.0  Unported  license,  as  described  at  http:// 
creativecommons.org/licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e2734 Immature B cells prefer CSR to IgE | Wesemann et al.
have shown that IgE switching largely occurs through a se-
quential  CSR  mechanism,  in  which  activated  B  cells  first 
switch from IgM to IgG1 via direct CSR from C to C1, 
followed by switching to IgE via a “second step” CSR from 
C1 to C (Yoshida et al., 1990; Siebenkotten et al., 1992; 
Mandler et al., 1993; Hodgkin et al., 1994). Indeed, these two 
CSR steps leading up to IgE switching can be separated by 
cellular division, hypermutation, and selection within germi-
nal centers (Erazo et al., 2007). In this regard, IgG1+ B cell inter-
mediates  in  sequential  CSR  have  been  proposed  to  be  a 
required part of the development of high-affinity IgE re-
sponses in vivo (Erazo et al., 2007). Sequential CSR to IgE has 
also  been  shown  to  occur  through  IgG  intermediates  in   
human B cells (Jabara et al., 1993; Baskin et al., 1997; Zhang 
et al., 1994; Mills et al., 1995). However, mice in which CSR 
to S1 is abrogated through mutation of I1 or deletion of S1 
can still undergo substantial switching to IgE, showing that an 
IgG1 intermediate is not absolutely required for switching to 
IgE (Jung et al., 1994; Misaghi et al., 2010). Whether or not 
intrinsic B cell properties exist that would favor direct IgE 
CSR versus direct IgG switching is unknown.
IgE antibodies play a central role in atopic diseases and in 
host protection against parasites. When engaged with antigen, 
specific IgE may activate mast cells and basophils to release po-
tent inflammatory mediators (Geha et al., 2003). Serum IgE is 
thus normally found at levels 3–4 orders of magnitude less that 
the other Ig isotypes and is produced by 
a correspondingly low number of IgE-
secreting cells (Saxon et al., 1980; King 
et al., 1990). Multiple different pri-
mary immunodeficiency conditions 
are associated with markedly elevated 
acceptor S region; these DSBs then are joined by classical non-
homologous end-joining, or an alternative DNA end-joining 
pathway (Yan et al., 2007), replacing C with a downstream 
CH gene. The activation-induced cytidine deaminase (AID) 
enzyme initiates both CSR and the related process of somatic 
hypermutation of Ig variable region exons via cytidine deami-
nation activity. During CSR, AID-induced mutations in S re-
gions are converted into DSBs. AID is targeted to S regions 
during CSR by transcription. In this regard, each S region is 
preceded by a promoter and a noncoding exon termed an “I” 
exon (Chaudhuri and Alt, 2004). Different forms of activation 
and/or cytokines provided by helper T cells or other cells can 
direct AID and, as a result, CSR to a particular target S region 
by specifically stimulating transcription from upstream I region 
promoters (Chaudhuri and Alt, 2004; Chaudhuri et al., 2007).
Stimulation of cultured splenic IgM+ B cells with an anti-
CD40 antibody (CD40) plus IL-4, which mimics in vivo 
activation by T helper type 2 (TH2) T cells, leads to the activa-
tion of NF-B and Stat6 transcription factors, respectively, 
which, together with other transcription regulators, induce 
germline (GL) transcription (GLT) from I1 and I promoters 
and CSR to C1 or C (Bacharier and Geha, 2000). Although 
CD40 plus IL-4 treatment theoretically can lead to direct CSR 
from C to either C1 or C, direct CSR to C occurs less 
frequently than to C1 (Snapper et al., 1988; Bottaro et al., 1994; 
Jung et al., 1994; Purkerson and Isakson, 1994). Various studies 
Figure 1.  Fetal liver-derived IBCs display 
IgE CSR preference. (A) WT BALB/c fetal liver 
cells from embryonic day 15 were cultured in 
the presence of IL-7–producing T220 fibro-
blasts for 7 d to form IBCs. These cells were 
subjected to B220+ magnetic separation and 
compared with adult splenic B cells purified in 
the same way. Immunophenotyping with  
the indicated surface markers is shown.  
(B) IgG1 and IgE stains of unstimulated adult 
splenic B cells and IBCs. (C and D) Graphs show-
ing total number of live B cells in millions (C) 
and percent death rates by trypan blue inclusion 
(D) during activation with CD40 plus IL-4.  
The experiments in A–D are representative of 
three independent experiments. (E) B220+ puri-
fied adult splenic B cells, IBCs, and BM B cells 
were then stimulated with CD40 plus IL-4 for 
4 d, followed by fusion with the NS-1 myeloma 
cell line. Hybridoma clones were analyzed by 
ELISA for IgM, IgG1, and IgE secretion. Shown 
are the mean values ± SD for three indepen-
dent experiments. Over 100 clones were analyzed 
per experiment. The p-values were calculated 
using the two-tailed Student’s t test.JEM Vol. 208, No. 13 
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We used this system to develop early B lineage and immature   
B cells that we will collectively call IBCs.
After 8 d in culture, embryonic day 15 liver cells develop 
into a population that expresses the pan–B lineage B220 and 
is uniformly positive for the early marker AA4.1, which stains 
the CD93 antigen. AA4.1/CD93 is found on all early stages 
of B lineage development, including the transitional B cell 
stage shortly after emigration from the BM to the spleen   
(Li et al., 1996; Allman and Pillai, 2008; Yamane et al., 2009). 
The IBCs are negative for markers found on more mature   
B cells such as IgD and CD21 (Fig. 1 A). About half of the 
IBCs are positive for surface IgM (Fig. 1 A) and all are nega-
tive for IgG1 and IgE (Fig. 1 B). When removed from the 
IL-7–containing culture conditions and stimulated for 4 d 
with CD40 plus IL-4, IBCs formed blasts and proliferated 
similarly to mature splenic B cells (Fig. 1 C), with at most 
modestly increased death rates (Fig. 1 D). To measure IgH 
CSR, activated B cells from day 4 cultures were fused to the 
NS1 hybridoma fusion partner, and the resulting hybridomas 
were tested by ELISA for secretion of IgM, IgG1, or IgE. 
These analyses revealed that, under the same stimulation con-
ditions, 63 ± 6% of IBC-derived hybridomas secreted IgE 
versus 27 ± 6% of splenic B cells (Fig. 1 E). Correspond-
ingly, we observed a trend, although nonsignificant, toward 
decreased IgG1-secreting hybridomas from IBCs (17 ± 11%) 
versus those from splenic B cells (35 ± 7%; Fig. 1 E). We also 
found that BM B lineage cells stimulated with CD40 plus 
IL-4 generated more (41 ± 6%) IgE-expressing hybridomas 
compared with splenic B cells (Fig. 1 E). Overall, these find-
ings demonstrate that CD40+IL-4–activated IBCs and BM 
B cells have a stronger tendency to undergo CSR to IgE 
compared with mature splenic B cells.
Splenic B cells from young mice and adult transitional  
B cells preferentially switch to IgE
Based on our finding that IBCs from fetal liver culture and 
BM B cells preferentially undergo class switching to IgE, we 
asked  if  im-
mature B cells 
in  the spleen 
also show such   
a  preference. 
serum IgE levels (Ozcan et al., 2008). In this context, “leaky” 
human SCID patients (e.g., having very low peripheral B and 
T cell numbers) caused by debilitating, but not complete, in-
activation of RAG proteins are associated with severe mani-
festations of immune dysregulation as exemplified by Omenn 
syndrome, which is characterized by immune deficiency, 
erythroderma,  lymphadenopathy,  tissue  inflammation,  and 
high IgE levels (Villa et al., 1998). Certain mouse models, 
such  as  mice  harboring  a  homozygous  point  mutation  in 
which serine 723 of RAG1 is converted to a cysteine (re-
ferred to here as Rag1S723C mutant mice) recapitulate features 
of Omenn syndrome. In particular, Rag1S723C mutant mice 
have a partial block of lymphocyte development at progenitor 
T and B cell stages caused by impaired ability to initiate  V(D)J 
recombination; but despite severely reduced peripheral B cells 
numbers, they may paradoxically have abundant serum IgE 
(Giblin et al., 2009; Walter et al., 2010). Although the molecu-
lar underpinnings of the different primary immunodeficiency 
states associated with hyper-IgE are diverse, many lead to im-
paired lymphocyte development and function (Geha et al., 
2003; Ozcan et al., 2008). In the current study, we test the 
hypothesis that B lineage cell developmental stage influ-
ences IgH CSR preference.
RESULTS
Fetal liver–derived IBCs display IgE CSR preference
Although CSR is usually considered in the context of mature 
B cells, previous studies have shown that immature B cells 
derived from fetal liver and BM cultures, as well as trans-
formed pre–B cell lines have the capacity to undergo CSR 
(Akira et al., 1983; Rothman et al., 1990a,b; Rolink et al., 
1996). Based on the finding that increased IgE is often as-
sociated with primary immune deficiencies that impair early 
B cell development, we hypothesized that CSR preference   
to C1 versus C might differ in mature versus immature   
B cells. To test this, we compared the C1/C preference of 
CD40 plus IL-4–activated mature B cells from adult (age 
2–4 mo) BALB/c spleens to that of immature B cells derived 
from BALB/c fetal liver cultures. Progenitor cells in the liver of 
WT day 15 mouse embryos develop into early B lineage cells, 
including pre–B and immature B cells, in the presence of IL-7–
producing fibroblasts (Borzillo et al., 1992; Milne et al., 2004). 
Figure 2.  Splenic B cells from young mice and 
adult transitional B cells preferentially switch to 
IgE. (A) Splenocytes from BALB/c mice age 4 mo 
versus 3.5 wk were enriched by B220+ selection be-
fore stimulation with CD40 plus IL-4. Activated  
B cells were fused to NS-1 myeloma cells. Class 
switching was assessed by ELISA analysis of hybrid-
oma clones. (B) Adult splenic B cells were enriched by 
CD43 selection before another round of AA4.1+ 
separation. Shown is a representative example of a 
FACS plot of purified B cells that was performed in-
dependently three times. (C) Bar graph showing mean 
percentage ± SD of purified B cells expressing AA4.1 
in AA4.1-enriched versus AA4.1-depleted fractions. 
(D) AA4.1-enriched versus -depleted fractions were 
stimulated, processed, and analyzed as in A. Shown 
are mean values ± SD. Each experiment shown was 
independently performed three times. Over 100 
clones were analyzed per experiment. The p-values 
were calculated using the two-tailed Student’s t test.2736 Immature B cells prefer CSR to IgE | Wesemann et al.
recently migrated to the mouse spleen, termed transitional 
B cells, generally make up a small percentage of adult splenic 
B cells and are defined by surface expression of AA4.1/CD93 (Li 
et al., 1996; Allman and Pillai, 2008; Yamane et al., 2009). To 
test CSR preference of transitional B cells compared with 
more mature splenic B cells, we purified splenic B cells from 
other splenocytes (based on CD43-negative selection), and 
then enriched for transitional B cells based on presence or 
absence of surface AA4.1/CD93. This procedure generated 
AA4.1/CD93-enriched  B  cells,  in  which  50%  were 
AA4.1/CD93+,  and  AA4.1/CD93-depleted  B  cell  frac-
tions, in which nearly 95% were AA4.1/CD93 (Fig. 2, B 
and C). After CD40 plus IL-4 stimulation and assay of 
IgE switching via the hybridoma ap-
proach, we found that 51 ± 2% of 
AA4.1/CD93-enriched splenic B cells 
versus only 34 ± 8% AA4.1/CD93-
depleted splenic B cells switched to IgE 
(Fig. 2 D; P = 0.02). These findings 
suggest that immature peripheral B cells, 
specifically transitional B cells, prefer-
entially switch to IgE compared with 
mature B cells.
Different kinetics of CSR to IgE  
in IBCs versus mature B cells
In activated mature B cells, IgE class 
switching is kinetically delayed rela-
tive to that of IgG1 potentially caused 
by the two-step sequential CSR mech-
anism operative in most of these cells 
(Yoshida et al., 1990; Siebenkotten et al., 
1992; Mandler et al., 1993; Hodgkin 
et al., 1994). Kinetically, measurement 
of  class  switching  is  best  done  by 
staining for surface expression of the 
Splenic B cells from young mice are known to naturally 
harbor substantially more immature B cells than older mice 
(Melamed et al., 1998; Monroe et al., 1999). Therefore, we 
first assayed for IgE switching after CD40 plus IL-4 activa-
tion of purified splenic B cells from young (3.5 wk) and 
older (4 mo) WT mice. Based on the aforementioned hy-
bridoma/ELISA  method,  68  ±  11%  of  activated  B  cells 
from young mice versus 44 ± 3% of those from older mice 
switch to IgE after such activation (Fig. 2 A). To assess 
whether the relative B cell maturity could explain the IgE 
CSR preference in younger versus older mice, we assayed 
switching in mature and immature splenic B cells isolated 
from spleens of adult mice (ages 2–4 mo). B cells that have 
Figure 3.  Different kinetics of CSR to 
IgE in IBCs versus mature B cells. (A) Devel-
opment of an assay to assess IgE switching. 
Activated B cells were subjected to fixation 
alone, or fixation and permeabilization with 
or without pretreatment with trypsin before 
staining for IgE and IgG1. This assay allows 
for the detection of intracytoplasmic IgE in 
the absence of receptor-bound (cytophilic) 
IgE. (B) B cells from BALB/c spleen (top row), 
IBCs (middle row), or splenic B cells from AID-
deficient mice (bottom row) were stimulated 
with CD40 plus IL-4. At indicated time 
points, cells were analyzed for IgG1 and IgE 
switching using the method outlined in A.  
(C and D) The experiment in B was indepen-
dently repeated a total of four times and the 
mean IgE (C) and IgG1 (D) expression ± SD are 
shown. The p-values were calculated using 
the two-tailed Student’s t test.JEM Vol. 208, No. 13 
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than those of adult splenic B cells (Fig. 3, C and D). Strik-
ingly, however, IBCs switched to IgE with significantly 
increased kinetics, reaching IgE expression levels 1 d be-
fore adult splenic B cells (Fig. 3, C and D). Purified splenic 
B cells from 1-wk-old mice, consisting mostly of transitional 
B cells (Loder et al., 1999; Fig. 4 A), show a similar kinetic 
preference for IgE CSR (Fig. 4, A–C). CSR to IgG1 is also 
attenuated  in  transitional  B  cells  compared  with  adult 
splenic B cells, although not to the degree of IgG1 CSR 
attenuation seen in IBCs (compare Fig. 3 D and Fig. 4 C). 
Thus, the IgE class switch preference of IBCs is associated 
with increased switching to this IgH isotype at earlier time 
points, suggesting that immature and transitional B cells 
may preferentially undergo direct CSR to C as compared 
with adult mature B cells.
Because genetic background has been shown to affect IgE 
responses (Drazen et al., 1996; Hogan et al., 1997; Mirotti et al., 
2010), we tested whether the IgE CSR preference we observe in 
BALB/c mice applies to other genetic backgrounds. IBCs from 
pure 129/Sv mice purchased directly from The Jackson Labora-
tory have reduced total IgE CSR (Fig. 5 A), reaching only 10 ± 
1.3% by day 5 in adult splenic B cells and 24 ± 2.1% in IBCs 
(Fig. 5, B and C); however, the IBC IgE CSR preference is 
maintained. In addition, IgE CSR appears earlier as it does in 
IBCs from BALB/c mice (compare Fig. 3 [C and D] to Fig. 5 
[B and C]). Transitional B cells from 1-wk-old C57BL/6 mice 
achieve total IgE and IgG1 levels similar to transitional B cells 
from 1-wk-old BALB/c mice (Fig. 5 A), and exhibit a compara-
ble IgE CSR preference as well (compare Fig. 4 [B and C] to 
Fig. 5 [E and F]). These data suggest that the IgE CSR preference 
is generalizable beyond the BALB/c ge-
netic background.
Decreased Stat6 phosphorylation  
and increased I GLTs in activated IBCs 
versus mature B cells
Because CSR to IgE and IgG1 is de-
pendent on Stat6 (Linehan et al., 1998; 
Bacharier and Geha, 2000), we compared 
Stat6 phosphorylation status of untreated 
and CD40 plus IL-4–activated splenic 
B cells and IBCs (Fig. 6 A). For this assay, 
B cells were activated for 45 min, 12 h, 
various IgH isotypes on activated B cells. However, such 
an assay has not been available for IgE switching because 
activated B cells express CD23/FcRII, which binds to se-
creted  IgE  present  in  activated  B  cell  culture  medium, 
thereby  rendering  all  cells  positive  (Rolink  et  al.,  1996). 
Therefore, we developed a method to remove both mem-
brane and receptor-bound IgE from the surface of cul-
tured B cells, allowing us to assay for intracytoplasmic IgE 
to provide a sensitive and reliable measure of IgE expres-
sion. For this purpose, we used trypsin treatment to effec-
tively remove both membrane-bound and cytophilic IgE 
from activated B cell surfaces (Fig. 3 A). As a result, sub-
sequent fixation and permeabilization of the cells allowed 
for specific staining of intracytoplasmic IgE-expression in 
the activated B cells (Fig. 3 A). Notably, membrane-bound 
IgG1 was not susceptible to trypsin-mediated removal from the 
cell surface because IgG1 (but not IgE) is still present after 
trypsinization/fixation and before permeabilization (Fig. 3 A, 
third panel from the left).
We used this novel intracytoplasmic IgE switching assay 
to measure the kinetics of IgG1 versus IgE expression in 
splenic B cells after 0, 2, 3, 4, and 5 d of in vitro stimulation 
with CD40 plus IL-4. In adult splenic B cells, we ob-
served the expected rapid induction of IgG1 versus IgE 
switching, with IgG1 switching reaching peak levels of 
30% by days 3 and 4, whereas IgE switching was low at 
day 3 and continued to increase between days 4 and 5 
(Fig. 3 B). Activated IBCs also reached peak IgG1 switch-
ing with similar kinetics to adult splenic B cells, although 
their maximal IgG1 levels were more than threefold less 
Figure 4.  IgE CSR preference in transitional 
B cells from 1-wk-old mice. (A) B cells from 
BALB/c adult spleen (top row) or splenic B cells 
from 1-wk-old BALB/c pups (bottom row) were 
stained with B220 and AA4.1 (left) and stimulated 
with CD40 plus IL-4 for the indicated time 
points (right). Cells were analyzed for IgG1 and 
IgE switching using the method outlined in Fig. 3 A. 
(B and C) The experiment in A was independently 
repeated a total of three times and the mean IgE 
(B) and IgG1 (C) expression ± SD are shown. The 
p-values were calculated using the two-tailed 
Student’s t test.2738 Immature B cells prefer CSR to IgE | Wesemann et al.
CD40/IL-4–mediated induction of phos-
pho-Stat6 is blunted in transitional B cells 
from 1-wk-old pups compared with adult 
splenic B cells, although the difference is 
more modest compared with IBCs (Fig. 6 B). 
Thus, the propensity of IBCs and transitional 
B cells to preferentially switch to IgE as com-
pared with mature B cells does not appear 
to result from an increase in total phospho-
Stat6 levels.
Both I1 and I promoter regions con-
tain Stat6-responsive elements, and transcrip-
tion initiated at I regions is required for CSR 
(Chaudhuri  and Alt,  2004). We  therefore 
hypothesized that GLT through S1 and S 
might be regulated differently in mature ver-
sus IBCs. Trimethylation of lysine 4 on his-
tone 3 (H3K4me3) within IgH CH promoters, 
I regions, and S regions has previously been 
shown to correlate with induction of CSR 
(Wang et al., 2009) and has recently been 
shown  to  be  an  initiating  event  in  GLT 
(Daniel et al., 2010). We therefore performed 
H3K4me3  chromatin  immunoprecipitation 
(ChIP) on resting and CD40/IL-4–activated 
mature B cells vs. IBCs, and then assayed 
for enrichment of  and 1 regions by quan-
titative PCR. Compared with adult splenic 
B cells, H3K4me4 ChIP revealed a modest 
nonsignificant reduction of  enrichment 
in IBCs (P = 0.17; Fig. 6 C) and a more 
striking reduction of 1 enrichment (P = 0.004; Fig. 6 D). 
Indeed, day 2 IBCs reach levels of 1 H3K4me3 similar to day 
0 in mature B cells (Fig. 6 D). Using quantitative PCR to test 
for steady-state GL transcript levels, we observed decreased 
I1 GL transcripts in IBCs relative to mature B cells (Fig. 6 E), 
correlating with diminished Stat6 phosphorylation in acti-
vated IBCs. Yet, activated IBCs revealed a modest increase in 
and 48 h, followed by staining with an antibody specific for 
tyrosine641-phosphorylated Stat6. Phosphorylated Stat6 lev-
els were then measured by flow cytometry. As expected, 
CD40 plus IL-4 treatment induced robust Stat6 phos-
phorylation in splenic B cells (Linehan et al., 1998); how-
ever, relative phospho-Stat6 levels were substantially reduced in 
activated IBCs at all time points tested (Fig. 4 A). In addition, 
Figure 5.  IgE CSR preference in immature and 
transitional B cells from other genetic back-
grounds. (A) Adult spleen (top row), or IBCs (bottom 
row) from 129/Sv mice were stimulated with CD40 
plus IL-4. Cells were analyzed for IgG1 and IgE 
switching using the method outlined in Fig. 3A.  
(B and C) The experiment in A was repeated in paral-
lel for three separate mice, and fetal liver prepara-
tions and the mean IgE (B) and IgG1 (C) expression ± 
SD are shown. (D) Splenic B cells from adults (top 
row) or 1-wk-old pups (bottom row) of C57BL/6 mice 
were stimulated with CD40 plus IL-4. Cells were 
analyzed for IgG1 and IgE switching using the 
method outlined in Fig. 3 A. (E and F) The experiment 
in D was performed for three separate mice per 
group, and the mean IgE (E) and IgG1 (F). Shown are 
averages ± SD. The p-values were calculated using 
the two-tailed Student’s t test.JEM Vol. 208, No. 13 
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to assay for differences in NF-B and 
AP-1  transcription  factor  components, 
namely, NF-B1/p105 (NFkB1), which 
is a component of NF-B, as well as jun 
and fos, which are components of the AP-1 
transcription factor complex. We found 
that transcript levels of each of these fac-
tors is reduced in IBCs compared with adult 
splenic B cells before stimulation, but that 
these differences disappear during activa-
tion with CD40 and IL-4 (Fig. 6, G–I). 
Additionally, differences in AID induc-
tion do not appear to explain differences in 
CSR preference between IBCs and splenic B cells because 
levels of AID are similar between the two groups (Fig. 6 J).
Factors previously shown to inhibit GLT of the I pro-
moter region include Bcl6 and ID2. Bcl6 inhibits I GLT 
by antagonizing Stat6-binding activity (Harris et al., 1999, 
2005), and ID2 down-regulates I GLT by inhibiting E2A 
proteins from binding to the I promoter (Sugai et al., 2003). 
In this context, both Bcl6-deficient (Harris et al., 2005) and 
ID2-deficient (Sugai et al., 2003) splenic B cells exhibit increased 
propensity to switch to IgE. Therefore, we investigated the 
the levels of I GL transcripts compared with adult splenic B 
cells on day 2, and similar levels thereafter (Fig. 6 F). Thus, both 
1 H3K4me3 and I1 GL transcript levels appear to be consis-
tently blunted in IBCs compared with adult splenic B cells, 
whereas more comparable levels of  H3K4me3 and I GL 
transcript levels are shared between IBCs and adult splenic 
B cells.
NF-B and AP-1 are important regulators of I1 and I GLT 
(Iciek et al., 1997; Lin et al., 1998b; Shen and Stavnezer, 1998; 
Shen and Stavnezer, 2001). We therefore used quantitative PCR 
Figure 6.  Decreased Stat6 phosphorylation 
and I1 GLTs in activated IBCs versus mature  
B cells. (A) B220-enriched cells were separated 
from fresh WT mouse spleens (SpL) or from day 8 WT 
fetal liver cultures (IBC) and either left unstimulated 
or stimulated with CD40 and IL-4 for the indicated 
times. Cells were then fixed and stained for intra-
cellular tyrosine-phosphorylated Stat6 and analyzed 
via FACS. The numerical value displayed is the mean 
fluorescence intensity (MFI) of the treated sample. 
This experiment was repeated with nearly identical 
results. (B) The MFI of anti–phospho-Stat6–stained 
resting and CD40+IL-4-activated adult splenic  
B cells versus transitional B cells from 1-wk-old pups. 
This experiment was performed in parallel for three 
independent mice from each group. (C and D) ChIP 
of resting and CD40+IL-4-activated mature B cells 
and IBCs to test for enrichment of  (C) and 1 
(D) sequences in anti-H3K4me3 precipitates using 
quantitative PCR. Signals were normalized to input 
after subtracting out the value of control IgG pre-
cipitates. Schematics of the  (C) 1 (D) loci show 
the location of the primers relative to promoter (P), 
I, and S regions. The ChIP experiments were per-
formed on five independent samples per group.  
(E–J) Quantitative PCR (qPCR) for the indicated 
transcripts at the indicated time points after CD40 
plus IL-4 stimulation. The values presented in E–J 
represent relative levels of expression of the indi-
cated transcripts normalized to GAPDH expression. 
Shown are the averages of three independent  
experiments. The error bars indicate ± SD. The  
p-values were calculated using the two-tailed  
Student’s t test. Asterisks indicate statistical  
significance (P < 0.05).2740 Immature B cells prefer CSR to IgE | Wesemann et al.
Increased direct  to  CSR in IBCs
Based on the increased kinetics of CSR to IgE in IBCs 
relative  to  mature  B  cells,  we  hypothesized  that  IBCs 
might be relatively more prone to undergo direct CSR to 
the S region than mature B cells. To assess direct  to  
CSR in IBCs versus adult splenic B cells, we used a semi-
quantitative PCR assay to detect transcripts from the cir-
cular DNA that is excised in the context of direct S to S 
CSR. In this assay, a forward primer in I together with a 
reverse primer within C detects hybrid I-C transcripts 
that arise from excised circular DNA generated via direct 
S to S CSR (Fig. 8 A). A single band is observed in this 
assay because the intronic region (containing the hybrid 
S-S junction) is spliced out of the excision circle tran-
script (Fagarasan et al., 2001), leaving the processed RNA 
containing I and C (Fig. 8, A and B). Because the larg-
est burst of IgE expression in IBCs occurs between day 2 
and 3 of stimulation, we assayed I-C hybrid transcripts 
at day 2 of stimulation. Densitometry values 
were used to evaluate fold change in circular 
transcript  levels  between  IBCs  and  adult 
splenic B cell levels, which revealed a 2.6-
fold  increase  (P  =  0.025)  in  direct  I-C 
CSR in the IBCs compared with the adult 
splenic B cells (Fig. 8, B and D) on day 2. 
There was also a mild, although nonsignifi-
cant decrease (33%; P = 0.12) in the levels of 
I1-C hybrid transcripts (Fig. 8 B, middle). 
Levels of direct I-C circle transcripts be-
tween splenic B cells and IBCs were similar 
on day 4 (Fig. 8, C and E). We also used our 
intracytoplasmic IgE-switching flow cytom-
etry assay to measure the proportion of cells 
double-positive for both IgM plus IgE and 
both IgG1 plus IgE, which may represent inter-
mediate states for cells that undergo direct CSR 
versus indirect switching to IgE (Kitayama 
possibility that increased CSR to IgE in activated IBCs 
versus activated mature B cells might result from decreased 
Bcl6 and/or ID2 levels in IBCs. Indeed, measurement of 
steady-state Bcl6 and ID2 transcript levels by quantitative 
PCR revealed that before activation, IBCs expressed approxi-
mately sevenfold lower levels (P < 0.001) of Bcl6 transcripts 
(Fig. 7 A) and 50% lower (P = 0.074) levels of ID2 transcripts 
(Fig. 7 B) compared with mature B cells. To directly test such 
a role for Bcl6, we used IBCs that overexpress Bcl6 from a Bcl6 
transgene under the control of the I promoter (Cattoretti 
et al., 2005). The I-Bcl6 IBCs express Bcl-6 at levels 5–30-
fold higher than in WT IBCs (Fig. 7 C). Notably, these were 
within the range of adult splenic B cell Bcl6 expression lev-
els (Fig. 7 A). After stimulating both I-Bcl6 and WT IBCs 
with CD40 plus IL-4, we found no difference in IgE or 
IgG1 switch preference (Fig. 7, D–F). Therefore, overexpression 
of  Bcl6  alone  does  not  change  the  IgE  CSR  preference 
within IBCs.
Figure 7.  Assessment of Bcl6 and ID2 transcript 
levels in IBCs compared with splenic B cells. Quanti-
tative PCR for Bcl6 (A) and ID2 (B) expression was  
performed on samples from unstimulated and 
CD40+IL-4–activated splenic B cells and IBCs. (C) Quan-
titative PCR of Bcl6 expression in WT IBCs versus IBCs 
from mice heterozygous for the I-Bcl6 transgene. Val-
ues were normalized to GAPDH. Shown are mean values ± 
SD of three independent experiments. The p-values  
were calculated using the two-tailed Student’s t test.  
(D) IBCs from WT mice (top row), and IBCs from I-Bcl6 
transgenic mice (bottom row) were stimulated with 
CD40+IL-4. Cells were analyzed for IgG1 and IgE 
switching using the intracytoplasmic staining method 
outlined in Fig. 3 A. The experiment in D was repeated a 
total of three times from three independent samples per 
group and the mean IgE (E) and IgG1 (F) expression ± SD 
for are shown.JEM Vol. 208, No. 13 
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Peripheral Rag1S723C B lineage cells exhibit CSR  
preference to IgE
Despite a blockade in lymphocyte development and decreased 
peripheral B cell numbers, some Rag1S723C mice have ele-
vated IgE levels (Giblin et al., 2009). Because we found that 
IBCs preferentially undergo CSR to IgE versus IgG1, we hy-
pothesized that increased peripheral B cell immaturity could 
contribute to increased IgE CSR in the RAG1S723C primary 
immune deficiency mouse model. Most B lineage splenic 
cells in these mutant mice are progenitor/precursor or IBCs 
based on AA4.1 staining (Fig. 10 A). To determine whether 
splenic B cells from Rag1S723C mutant mice display IgE CSR 
preference, B lineage cells from spleens of 7–12 wk old mu-
tant and WT littermates were enriched using B220+ selection 
et al., 2008; Zhang et al., 2008). Notably, we found sig-
nificantly increased IgM/IgE double-positive cells in acti-
vated  IBCs  versus  activated  mature  B  cells  at  day  3  of 
stimulation (Fig. 8, F and G). There were also significantly 
fewer IgG1/IgE double-positive cells at day 4 and 5 in ac-
tivated IBCs relative to activated mature B cells (Fig. 3 B 
and Fig. 8 H). We also find that transitional B cells from   
1-wk-old pups harbor more IgM/IgE double-positive inter-
mediates on day 3 (Fig. 9, A and B). Moreover, there is a 
trend, though not significant (P = 0.1), of decreased IgG1/IgE 
double-positive cells in the transitional B cells compared 
with adult splenic B cells (Fig. 9 C). Together, these data 
are consistent with IBCs being more prone to undergo direct 
CSR to IgE.
Figure 8.  Increased direct IgM to IgE CSR in IBCs. (A) Simplified schematic of the IgH locus showing class switch recombination products re-
sulting from direct S to S recombination. General location of PCR primers in I and C are shown as half arrows. (B and C) PCR assay showing 
excision circle transcript signals unique to transcripts only from direct  to  (top lanes) or direct  to 1 (middle lanes) CSR from adult splenic  
B cells versus IBCs after 2 (B) or 4 d (C) of culture. Actin was used as a loading control (bottom lanes). Results are representative of three independent 
experiments. (D and E) Quantification of densitometry of direct  to  CSR. Fold induction was calculated by measuring fold change compared with 
adult splenic B cells on day 2 (D) and 4 (E). Shown are mean values ± SD for three independent experiments. The p-values were calculated using the 
two-tailed Student’s t test. (F–H) The intracytoplasmic staining technique described in Fig. 3 A was used to simultaneously detect expression of IgE 
and IgM (F), as well as simultaneous IgE and IgG1 expression (shown in Fig. 3 B) on CD40 plus IL-4–activated B cells for the indicated times.  
(G and H) Line graphs show percent IgE, IgM double-positive B cells (G) and percent IgG1, IgE double-positive B cells (H) in activated adult splenic  
B cells compared with IBCs. Shown are mean values ± SD of three independent experiments. The p-values were calculated using the two-tailed Stu-
dent’s t test. Asterisks indicate statistical significance (P < 0.05).2742 Immature B cells prefer CSR to IgE | Wesemann et al.
DISCUSSION
In this study, we report that CD40/IL-4–activated imma-
ture and transitional B cells preferentially undergo CSR to 
IgE versus IgG1 compared with mature splenic B cells. We 
also show that IBCs switch to IgE though a mechanism in-
volving increased direct CSR from IgM to IgE. The ob-
servation of decreased S1 H3K4me3 and reduced I1 GL 
transcripts  in  CD40  plus  IL-4–activated  IBCs  compared 
with  mature  B  cells  suggests  that  I1  is  more  poised  for 
CD40+IL-4–mediated induction of GLT in mature cells, 
whereas  H3K4me3 and I GL transcripts are closer to ma-
ture B cell levels. In addition, we find that these differences 
occur in the context of a lower amount of total C40+IL-4–
induced phospho-Stat6 levels in the IBCs. Our studies there-
fore identify B cell maturity as an intrinsic B cell property 
that affects CSR choice of IgE versus IgG1.
Our proposed mechanistic model to explain the dif-
ferential  preference  of  CD40+IL-4-activated  immature 
versus mature B cells to undergo CSR to IgG1 versus IgE   
is that, upon developmental transition from the immature 
stage to the mature B cell stage, B cells reduce suppressive 
activity at the I1 promoter. This change in promoter in-
ducibility results in relatively more CD40+IL-4–mediated 
I1 GLT and AID targeting of S1 in mature B cells, lead-
ing them to switch first to IgG1. Correspondingly, the weaker 
induction of 1 H3K4me3 and I1 GLT compared with   
 H3Keme4 and I GLT induction makes S a relatively 
favorable target for direct CSR to S within CD40+IL-4-
activated  immature  and  transitional  B  cells.  Indeed,  in-
creased IgE CSR is observed in mature B cells that cannot 
switch to IgG1 because of deletion of S1 (Misaghi et al., 
2010). Because Stat6 is involved in the regulation of both 
I1 and I GLT (Linehan et al., 1998), one may speculate 
that  the  decreased  levels  of  total  CD40+IL-4–induced 
phospho-Stat6 that we observed in the IBCs versus mature 
B cells may endow the I promoter with a competitive 
advantage over the I1 promoter. In this regard, it is con-
ceivable that the I promoter, which binds Stat6 with 10-
fold higher affinity compared with the I1 promoter (Mao 
before stimulation with CD40 plus IL-4 for 4 d to induce 
IgE and IgG1 CSR. IgE CSR occurred in 55 ± 9% of the 
Rag1S723C B cells compared with 18 ± 3% in WT B cells 
from littermate mice (Fig. 10 B). Southern blotting of hy-
bridoma DNA of IgE+ clones confirmed IgE CSR at the 
DNA level (unpublished data). Together, these results sug-
gest that Rag1S732C splenic B lineage cells are skewed toward 
an early developmental phenotype and preferentially switch 
to IgE compared with IgG1 when stimulated with CD40 
and IL-4.
Figure 9.  Increased IgE, IgM double-positive cells in CD40+IL-4-activated transitional B cells. (A) The intracytoplasmic staining technique 
described in Fig. 3 A was used to simultaneously detect expression of IgE and IgM (A), as well as simultaneous IgE and IgG1 expression (shown in Fig. 4 A) 
in adult splenic B cells versus transitional B cells from 1-wk-old mouse pups. (B and C) Line graphs show percent IgE, IgM double-positive B cells (B), and 
percent IgG1+IgE double-positive B cells (C) in activated adult splenic B cells compared with transitional B cells. Shown are mean values ± SD of three 
independent experiments. The p-values were calculated using the two-tailed Student’s t test. Asterisks indicate statistical significance (P < 0.05).
Figure 10.  Peripheral Rag1S723C B lineage cells exhibit CSR prefer-
ence to IgE. (A) Rag1 S723C splenic (SpL) cells and cells from WT litter-
mate control spleen and BM were stained for CD19 (to define B lineage 
cells) and AA4.1. The plots shown are representative of four experiments. 
(B) WT and Rag1 S723C B cells were purified based on B220+ or CD19+ 
selection before being stimulated for 4 d with CD40 plus IL-4. They were 
then fused with the NS-1 myeloma fusion partner. Individual hybridoma 
clones were then assayed for IgG1, IgE, and IgM secretion by ELISA. 
Shown are mean values ± SD for four independent experiments. The  
p-values were calculated using two-tailed Student’s t test. Asterisks  
indicate statistical significance (P < 0.05).JEM Vol. 208, No. 13 
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Our findings reveal a functional link between B cell de-
velopmental maturity and inducibility of the I1 and I pro-
moter regions. Accordingly, our data reveal B cell maturity 
as an intrinsic regulatory factor that can affect downstream 
antibody functionality by impacting IgH isotype preference. 
In addition, the B cell developmental state may have an im-
pact on IgE antibody specificity by regulating direct versus 
sequential CSR to IgE. In this regard, an IgG1+ B cell inter-
mediate has been proposed to be required for development 
of somatically hypermutated and affinity matured antigen-
specific IgE molecules in vivo (Erazo et al., 2007) because 
IgE-expressing B cells, but not those expressing IgG1, are 
excluded from germinal center reactions (Erazo et al., 2007). 
Our finding of earlier progression to IgE in IBCs via in-
creased direct IgM to IgE CSR may also imply that antibodies 
that mature this way may bypass the process of hypermuta-
tion  and  selection  within  germinal  centers.  Whether  in-
creased direct CSR to IgE plays a role in primary immune 
deficiencies with high IgE, and whether this has an effect on 
IgE affinity/specificity in these conditions, is the subject of 
ongoing study.
MATERIALS AND METHODS
Mice. Mice harboring the RAG1-S723C knock-in mutation at the endog-
enous locus were previously described (Giblin et al., 2009). Heterozygous 
breeding pairs produced experimental homozygous mice with WT litter-
mates that served as controls. T. Honjo (Kyoto University, Kyoto, Japan) 
provided AID/ mice. The I-Bcl6 mice were a gift from R. Dalla-Favera 
(Columbia University, New York, NY) and were maintained on a C57BL/6 
background. WT BALB/c, 129/Sv, and C57BL/6 mice were purchased 
from The Jackson Laboratory. All experiments with mice followed the pro-
tocols approved by the Boston Animal Care Facility of the Children’s Hos-
pital, Boston, MA 02115.
Splenic B cell purification and culture. Splenic and BM B lineage cells 
were isolated by B220+ selection via magnetic columns (Miltenyi Biotec) 
before stimulation with CD40 plus IL-4 to induce CSR to IgG1 and 
IgE,  as  previously  described  (Yan  et  al.,  2007).  Cytokine  sources  were 
CD40  (eBioscience)  and  IL-4  (eBioscience).  For  AA4.1  enrichment, 
splenic B cells were first enriched by CD43 separation followed by AA4.1+ 
magnetic separation.
Intracytoplasmic IgE staining. Intracytoplasmic staining and flow cytom-
etry were performed on days 0, 2, 3, 4, and 5 with anti–IgE-FITC, anti–IgG1-
PE, and anti–B220-PE-Cy5 after incubating cells in 0.05% trypsin for 2 min   
in PBS at room temperature, followed by fixation in 3% buffered parafor-
maldehyde for 10 min at 37ºC. Cells were then permeabilized with 90% 
cold methanol for 30 min on ice, washed twice with PBS, and stained for 
flow cytometry.
Hybridoma  analysis  for  CSR. 5–10 million CD40/IL-4–stimulated   
B cells from each mouse were fused with NS-1 fusion partner myeloma cells 
on day 4 and recovered after 7 d selection with 1× hypoxanthine-aminopterin-
thymidine medium. Single clones were isolated and grown before ELISA 
was done on their supernatants to measure secreted IgM, IgG1, and IgE. 
Over 100 clones were analyzed for each individual experiment, and at 
least 3 experiments were performed per condition. Only clones that were 
single positive for one of the three IgH isotypes tested were counted. 
Clones that were negative for all IgH isotypes or positive for more than 
one IgH isotype were found at very low levels (<5% of total clones) in all of 
the samples.
and Stavnezer, 2001), may potentially usurp Stat6 binding at 
the expense of I1, thus favoring I GL transcription within 
immature and transitional B cells. However, when we manu-
factured a modest reduction phospho-Stat6 levels in mature   
B cells by using decreased amounts of IL-4 (while maintain-
ing CD40 levels at a constant), we observed a reduction in 
both IgG1 and IgE CSR (unpublished data). In this regard, 
IgE CSR preference in IBCs cannot be explained by weaker 
IL-4 signals alone.
Although not apparent by the H3K4me3 ChIP experi-
ments, one may also consider the possibility that I GLT and 
S accessibility is reduced in mature B cells compared with 
IBCs, given the modest decrease in day 2 I GL transcripts in 
mature B cells. In this regard, two important candidate I tran-
scriptional inhibitors are Bcl6 and ID2 (Ozcan et al., 2008). 
Indeed, we find that Bcl6 expression is significantly lower in 
IBCs versus mature splenic B cells, which may play a role in 
the increased I GLT observed in CD40+IL-4-activated 
IBCs compared with mature B cells. However, our Bcl6 over-
expression experiments suggest that decreased Bcl6 in IBCs is 
not solely responsible for their IgE switch preference.
The observation that certain primary immune deficien-
cies with seemingly unrelated genetic underpinnings are 
associated with very elevated levels of IgE has been the sub-
ject of great interest since these primary immune deficiencies 
may provide clues into the regulation of IgE CSR and pro-
duction (Geha et al., 2003; Ozcan et al., 2008). Proposed 
mechanisms for increased IgE in primary immune deficiency 
include  defective  and/or  imbalanced  cytokine  production 
and regulatory T cell malfunction, but a unifying mechanism 
remains elusive (Ozcan et al., 2008). The effect of B cell de-
velopmental differences on class switch preference has not 
been addressed until now. Indeed, these studies highlight a need 
to examine B cell developmental effects in targeted knockout 
or transgenic mice that modulate CSR because it is not diffi-
cult to foresee situations where deletion of genes involved in 
immature/mature B cell ratios could indirectly affect CSR. 
In this regard, we find that the murine Rag1S723C immune 
deficiency model contains increased proportions of periph-
eral immature B cells that preferentially switch to IgE in   
ex vivo cultures when stimulated with CD40 plus IL-4, 
suggesting a model whereby positioning of developmentally 
immature B cells (in places where they may be exposed to 
activating cytokines and T cell help) may permit a higher fre-
quency of CSR to IgE. Consistent with the idea that intrinsic 
differences within B cells may play a role in regulating prob-
ability of CSR to IgE, perturbations in B cell development 
have been reported in a specific primary immune deficiency 
(Wiskott-Aldrich syndrome) associated with elevated IgE 
levels (Park et al., 2005). In addition, allogeneic BM trans-
plantation, which temporarily places developing B lineage 
cells in the periphery, is associated with a transient, but sharp 
increase in IgE as early as 14 d after transplant (Geha et al., 
1980). Our studies also provide potential insights for why 
children have higher total IgE levels compared with adults 
(Grundbacher, 1976).2744 Immature B cells prefer CSR to IgE | Wesemann et al.
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